Evidence map›Paper›PMID 40067137›Full record

ArticleClinical science (London, England : 1979)2025

Trbp inhibits cardiac fibrosis through TGF-β pathway-mediated cross-talk between cardiomyocytes and fibroblasts.

Bo Pan, Di Hu, Yao Wei Lu, Jing Luo, Xiao Hui Xu, Haipeng Guo, Rui Deng, Zhuomin Liang, Yi Wang, Qing Ma and 3 more

Abstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bo PanDepartment of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.ORCID 0009-0001-2139-1632
Di HuDepartment of Otorhinolaryngology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yao Wei LuDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.ORCID 0000-0001-6200-2974
Jing LuoDepartment of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
Xiao Hui XuChina International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
Haipeng GuoDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.
Rui DengDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.
Zhuomin LiangDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.ORCID 0000-0001-6754-9346
Yi WangDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.ORCID 0000-0002-0291-5314
Qing MaDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.ORCID 0000-0002-5625-1330
John D MablyThe Center for Regenerative Medicine and USF Health Heart Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33602, U.S.A.ORCID 0000-0002-3626-9090
Jie TianDepartment of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
Da-Zhi WangDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston MA 02115, U.S.A.ORCID 0000-0003-1774-6549

Funding

MOLECULAR MECHANISMS OF DYSTROPHIC CARDIOMYOPATHYR01HL149401 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, DA-ZHI · 2019 to 2022
$2.3M
Function and Mechanism of the Intercalated Disc Protein XinB in Cardiomyocyte Proliferation and Cardiac RegenerationR01HL168900 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI Da-Zhi Wang · 2023 to 2026
$2.2M
lncRNA Function and Mechanisms during Cardiac Development and DiseaseR01HL165794 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI Da-Zhi Wang · 2023 to 2026
$2.2M
MicroRNAs, cardiac function and cardiomyopathyR01HL138757 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, DA-ZHI · 2017 to 2020
$2.1M
NHLBI NIH HHS R01 HL138757NHLBI NIH HHS R01 HL149401NHLBI NIH HHS R01 HL165794NHLBI NIH HHS R01 HL168900
6 · The paper itself

Abstract

Cardiac remodeling in response to disease or tissue damage severely impairs heart function. Therefore, the description of the molecular mechanisms responsible is essential for the development of effective therapies. Trbp (Tarbp2) is a multifunctional RNA-binding protein that is essential during heart development, but its role in the adult heart and cardiac remodeling remains unknown. We generated inducible conditional knockout mice to delete Trbp from cardiomyocytes in young adults (Trbp-cKOs). While Trbp-cKO mice did not display a detectable phenotype, under stress conditions induced by transverse aortic constriction pressure overload, they rapidly developed severe heart failure; this was associated with maladaptive cardiac remodeling and increased interstitial fibrosis. RNA-sequencing revealed the induction of a fibrotic gene expression network and the TGF-β signaling pathway in Trbp-cKO hearts. In cultured neonatal rat ventricle cardiomyocytes (NRCMs), inhibition of Trbp resulted in an induction of the expression of both Tgfβ2 and Ltbp2; in contrast, Trbp overexpression repressed Tgfβ2 expression. Knockdown of Trbp in NRCMs that were co-cultured with neonatal rat cardiac fibroblasts (NRCFs) resulted in an increase in fibrotic gene expression. However, knockdown of Trbp in NRCMs combined with knockdown of Tgfβ2 in NRCFs using the same co-culture system failed to induce the same change in fibrotic gene expression. These data provide evidence for a critical role for Trbp in regulating cardiac fibrosis during cardiac remodeling mediated by cross-talk between cardiomyocytes and fibroblasts. The link to TGF-β signaling also highlights its importance and reveals a novel approach to intervention by targeting of Trbp.

Indexed as

Cell CommunicationFibroblastsMyocardiumMyocytes, CardiacRNA-Binding ProteinsTransforming Growth Factor betaAnimalsCells, CulturedDisease Models, AnimalFibrosisHeart FailureMaleMiceMice, Inbred C57BLMice, KnockoutRatsRNA-Binding ProteinsTransforming Growth Factor betaTransforming Growth Factor beta2cardiac fibrosiscross-talkheart failureTGF-βTrbp

Identifiers

PMID40067137
PMCPMC12203991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.